Pediatric Endocrinology News

The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to delay the disease’s onset may be changing the conversation.

A few months ago, I would have questioned the value of universal screening for type 1 diabetes because we did not have anything to offer people who are at risk for the disease. However, we now have a drug — teplizumab-mzwv — that can delay the onset of type 1 diabetes. That is an important advance.

All newborns should be screened for congenital hypothyroidism within 48 to 72 hours of birth, and prompt treatment after diagnosis is necessary to avoid adverse outcomes, according to a report from the American Academy of Pediatrics.

The AAP on Monday released its first clinical guidance on obesity in 15 years, suggesting that physicians offer adolescents as young as age 12 years weight loss medication and evaluate teens for metabolic and bariatric surgery.

Children with type 1 diabetes missed nine more school days, on average, per year than children without the disease, according to new research published in Diabetes Care.

Acceptance-based therapy was as effective as enhanced care for weight loss among adolescent girls with overweight or obesity, according to a pilot randomized controlled trial published in Childhood Obesity.

The FDA approved once-weekly semaglutide for the treatment of obesity among adolescents aged 12 to 17 years with an initial BMI in the 95th percentile for age and sex, according to a press release.

Researchers hypothesize that the number of youths in the U.S. with diabetes is likely to substantially increase in future decades, highlighting the need for diabetes prevention, according to estimates published in Diabetes Care.

Adolescents with overweight or obesity consume more calories during snacking and eat more snacks with added sugars, dairy, solid fats and refined grains than those with normal weight, according to a study published in Obesity.

School-aged children gained more excess weight during the COVID-19 pandemic compared with the year prior, with a greater degree of weight gain observed among Black and Hispanic children, according to data published in Obesity.